Fermenta Biotech informs about outcome of board meeting

10 Feb 2023 Evaluate
Fermenta Biotech has informed that the Board of Directors of the Company at its meeting held on February 10, 2023 has approved the unaudited financial results for the quarter and nine months ended December 31, 2022 (Standalone and Consolidated) as enclosed. It enclosed the Limited Review Report dated February 10, 2023 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, S R B C & Co. LLP. The Board meeting commenced at 11.45 am and concluded at 01.00 pm.

The above information is a part of company’s filings submitted to BSE.

Fermenta Biotech Share Price

340.35 20.20 (6.31%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×